Definition
Androgen ablation therapy is a therapeutic modality with the purpose of removing or reducing (ablating) male androgens – testosterone and dihydrotestosterone produced endogenously. This type of therapy is primarily used in metastatic prostate cancer, as opposed to localized disease where the tumor mass can be surgically removed. Procedures to reduce/remove endogenous androgens may include combinations of orchiectomy, antiandrogens, or gonadotropin-releasing hormone agonists/antagonists in combinations with antiandrogens. Androgen receptor antagonists include flutamide, bicalutamide, and nilutamide.
Although classified as androgen ablaters, 5α-reductase inhibitors are approved primarily for treatment of benign prostatic hyperplasia. 5α-reductase inhibitors also reduce levels of dihydrotestosterone by preventing its conversion from testosterone and include finasteride and dutasteride. Treatment for benign...
See Also
(2012) Testosterone. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3660. doi: 10.1007/978-3-642-16483-5_5741.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Schwab, M. (2014). Androgen Ablation Therapy. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_6775-3
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_6775-3
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences